Merit Medical Systems has purchased $105 million in assets from EndoGastric Solutions.
The deal will expand Merit's endoscopy portfolio for the treatment of chronic gastroesophageal reflux disease (GERD) and will add $30 million in annual revenue to the company's bottom line. EndoGastric Solutions' EsophyX Z+ relieves GERD symptoms via a procedure called transoral incisionless fundoplication, Merit noted.